Xbox Kinect™ Training for Stroke Rehabilitation
Launched by ANKARA UNIVERSITY · Apr 29, 2016
Trial Information
Current as of April 29, 2025
Completed
Keywords
ClinConnect Summary
This study was planned as a single-blind, randomized controlled, pilot trial. It was approved by the Ankara University Faculty of Medicine Ethics Committee and was conducted in accordance with the Declaration of Helsinki. Stroke patients who were hospitalized for inpatient rehabilitation at the Ankara University Faculty of Medicine, Cebeci Research and Application Hospital, Physical Medicine and Rehabilitation Clinic from December 2012 to March 2014, were assessed to determine their eligibility for the study. All patients were diagnosed with stroke by a neurologist according to World Health...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • First-time ischemic or hemorrhagic stroke occurring in the last 9 months
- • Between 18 and 80 years of age
- • Brunnstrom motor recovery stage in the affected upper extremity ≥ 3
- • Ability to understand and follow simple explanations and commands
- • Mini-Mental State Examination score of ≥ 24
- Exclusion Criteria:
- • History of epilepsy or seizure (except childhood febrile seizures)
- • Arthritis or pain restricting the repetitive training of the affected upper extremity
- • Severe aphasia
- • Neglect phenomena
- • Cognitive or psychiatric disorders
- • ≥ Grade 3 spasticity in the affected upper extremity according to Modified Ashworth Scale
- • Medical conditions which may affect physical performance or the physical activity may become unsafe (unstable angina, myocardial infarction within the last 3 months, uncontrolled blood pressure, pulmonary disease, etc.)
- • Participation in another clinical trial
About Ankara University
Ankara University, a prominent institution in Turkey, is dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on scientific rigor and ethical standards, the university collaborates with various stakeholders to design and implement studies that address critical health challenges. Leveraging a diverse network of experienced researchers and state-of-the-art facilities, Ankara University aims to contribute significantly to the global medical community by generating valuable insights and fostering the development of effective therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Patients applied
Trial Officials
Haydar GOK, Professor
Principal Investigator
Ankara University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials